Status:
COMPLETED
Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.
Lead Sponsor:
Pfizer
Conditions:
Heart Valve Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
Eligibility Criteria
Inclusion
- \>=18 years of age subjects with stable concomitant diseases with BMI \>=30 kg/m2
Exclusion
- Pregnant females
- Those with unstable/new onset diseases
- Those who are on agents known to be associated with cardiac valvular heart disease
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
End Date :
July 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00359489
Start Date
April 1 2007
End Date
July 1 2007
Last Update
September 17 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511-5473